|
196 |
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. |
Goyal A, Mehta SR, Díaz R, Xavier D, Pais P, Yusuf S, et al; |
Circulation |
2009 |
|
197 |
Dabigatran versus warfarin in patients with atrial fibrillation. |
Connolly SJ, Ezekowitz MD, Yusuf S, Alings M, Xavier D, et al; |
N Engl J Med. |
2009 |
|
198 |
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction. |
Goyal A, Mehta SR, Xavier D, Pais P, Yusuf S, et al; |
Am Heart J. |
2009 |
|
199 |
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. |
Yusuf S, Pais P, Xavier D, Sigamani A, Mohan V, Gupta R, Thomas N, et al; |
Lancet |
2009 |
|
200 |
The need to test the theories behind the Polypill: rationale behind the Indian Polycap |
*Xavier D*, *Pais P*, Sigamani A, Pogue J, Afzal R, Yusuf S; Indian Polycap Study (TIPS) Investigators |
Nat Clin Pract Cardiovasc Med |
2009 |
|
201 |
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy |
Mehta SR, Bassand JP, , Yusuf S; CURRENT-OASIS 7 Steering Committee |
Am Heart Journal |
2008 |
|
202 |
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. |
McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Kazmi K, Yusuf S, et al; |
Lancet 2008. |
2008 |
|
203 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. |
Sacco RL, Diener HC, Yusuf S, Pais P et al; |
N Engl J Med. |
2008 |
|
204 |
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. |
Oldgren J, Wallentin L, Afzal R, Pais P, Xavier D, Yusuf S, et al; |
Eur Heart J. |
2008 |
|
205 |
Telmisartan to prevent recurrent stroke and cardiovascular events. |
Yusuf S, Diener, Pais P, et al; |
N Engl J Med. |
2008 |
|
206 |
Polypharmacotherapy for primary prevention of cardiovascular disease. |
Xavier D, Devereaux PJ, Pais P, Yusuf S. |
Indian Heart J. |
2008 |
|
207 |
Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaem |
Diener HC, Sacco RL, Yusuf S, Pais P et al; |
Lancet Neurol. |
2008 |
|
208 |
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. |
Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, Joshi P, Kerkar P, Thanikachalam S, Haridas KK, Jaison TM, Naik S, Maity AK, Yusuf S; CREATE registry investigators. |
Lancet. |
2008 |
|
209 |
Randomized trials in vulnerable populations. |
Cook D, Moore-Cox A, Xavier D, Lauzier F, Roberts I. |
Clin Trials. |
2008 |
|
210 |
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. |
Devereaux PJ, Yang H, Yusuf S, Xavier D, Pais P, et al. |
Lancet. |
2008 |